7-year Follow-Up Outcomes after Stereotactic Ablation Radiotherapy for Stage I NSCLC: Results of a Phase Π Clinical Trial

BACKGROUND: We evaluated the efficacy, pattern of failure, and toxicity of stereotactic ablative radiotherapy (SABR) for medically inoperable clinical stage I non-small cell lung cancer (NSCLC) in a prospective clinical trial with 7 years follow-up. METHODS: Eligible patients with histologically con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Sun, Bing, Brooks, Eric D., Komaki, Ritsuko, Liao, Zhongxing, Jeter, Melenda, McAleer, Mary, Allen, Pamela K., Balter, Peter A., Welsh, James D., O’Reilly, Michael, Gomez, Daniel, Hahn, Stephen. M., Roth, Jack A., Mehran, Reza J., Heymach, John V., Chang, Joe Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544582/
https://ncbi.nlm.nih.gov/pubmed/28346656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30693
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados